Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 19 → 20·16:29, 28 Aug 2025
Difference between revision 19 and revision 20 of Qingdao Saber Technology Pharmaceutical. 16 lines changed; the page grew by 993 bytes.
| Revision 19 — 13:40, 22 Aug 2025 ForgeryFinder (talk) fix unit 5,492 bytes +29 | Revision 20 — 16:29, 28 Aug 2025 DeadSpaceDot (talk) label community tally as self-reported 6,485 bytes +993 | ||
|---|---|---|---|
| 12 | | Industry = Research-compound supply | 12 | | Industry = Research-compound supply |
| 13 | | Shop domain = [https://qingdaosabertechnology.com/ Visit QST] | 13 | | Shop domain = [https://qingdaosabertechnology.com/ Visit QST] |
| + | 14 | <!-- Products and documentation --> | |
| + | 15 | | Product scope = peptides, SARMs, injectable oils and raw materials | |
| + | 16 | | Catalogue size = 350+ listings (self-reported) | |
| + | 17 | | Documentation = Batch certificate of analysis reported with orders | |
| + | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | |
| 14 | }} | 19 | }} |
| 15 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 33 | 38 | ||
| 34 | No certification claim has been corroborated, and the organisation's own statements about capability are self-published.{{r|selfpub,gmp}} | 39 | No certification claim has been corroborated, and the organisation's own statements about capability are self-published.{{r|selfpub,gmp}} |
| + | 40 | ||
| + | 41 | == Product range == | |
| + | 42 | | Class | Representative listings | Documentation reported | | |
| + | 43 | |---|---|---| | |
| + | 44 | | Incretin analogues | Semaglutide, tirzepatide | Certificate, purity; water inconsistent | | |
| + | 45 | | Research peptides | Repair and secretagogue peptides | Certificate, purity | | |
| + | 46 | | SARMs | Bulk and capsuled | Certificate, purity | | |
| + | 47 | | Raw materials and oils | Bulk | Certificate, limited detail | | |
| + | 48 | ||
| + | 49 | == Independent testing record == | |
| + | 50 | Submitted reports on QST material to July 2026 are fewer than for the larger entries, reflecting a smaller reported customer base rather than a quality finding.{{r|reports}} Reported [[Area percent purity|area percent]] figures have been high in most cases. | |
| 35 | 51 | ||
| 36 | == References == | 52 | == References == |